VJHemOnc is committed to improving our service to you

SOHO 2020 | Vaccines and immunotherapy in hematological malignancies

VJHemOnc is committed to improving our service to you

David E. Avigan

David E. Avigan, MD, Beth Israel Deaconess Medical Center and Dana-Farber/Harvard Cancer Center, Boston, MA, discusses the use of vaccines and immunotherapy in hematological malignancies, including the presentation of multiple antigens on a platform of dendritic cell co-stimulation, as well as the importance of understanding the tumor microenvironment. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter